16.04.2020 Novavax Inc Daily Analysis

16.04.2020 Novavax Inc Daily Analysis Novavax Inc (NVAX) 17.53usd, -0.47, -2.61% Novavax is one of the pharmaceutical companies that has been doing well for the past three months especially with its clinical stage for the Nano Flu that came out positive but it also had some notable failures recently their respiratory syncytial virus (RSV) vaccine failed multiple clinical trials. This is why it has been volatile lately and today it went down with almost 3 percent and it is trading on 17.53usd because some investors are skeptical about the company especially considering the fact that the stock used to trade on 300 dollars before per share and now it is on 17 dollars and some investors already are having doubts and disappointments about the company.